Cargando…
Nicorandil improves myocardial function by regulating plasma nitric oxide and endothelin-1 in coronary slow flow
BACKGROUND: Coronary slow flow (CSF) is a special coronary microvascular disorder. The pathogenesis and effective therapeutics of CSF remain unclear. This study aimed to evaluate the global and regional functions of the left ventricle (LV) and investigate the efficacy of nicorandil in patients with...
Autores principales: | Chen, Zuoyuan, Chen, Xiuhua, Li, Shan, Huo, Xuezhen, Fu, Xiuxiu, Dong, Xiaonan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323571/ https://www.ncbi.nlm.nih.gov/pubmed/25325437 http://dx.doi.org/10.1097/MCA.0000000000000179 |
Ejemplares similares
-
Nicorandil Improves Left Ventricular Myocardial Strain in Patients With Coronary Chronic Total Occlusion
por: Chen, Shaomin, et al.
Publicado: (2022) -
Nicorandil Decreases Renal Injury in Patients With Coronary Heart Disease Complicated With Type I Cardiorenal Syndrome
por: Du, Xiaozhi, et al.
Publicado: (2021) -
Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention
por: Zhao, Xiao-Tao, et al.
Publicado: (2019) -
Clinical Effect of Nicorandil Combined with Aspirin in the Treatment of Myocardial Ischemia
por: Li, Yue, et al.
Publicado: (2022) -
Effect of nicorandil treatment adjunctive to percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis
por: Zhou, Jin, et al.
Publicado: (2020)